Food News and Research

RSS

Belgian FAMHP approves Oncolytics' Phase 3 combination trial of REOLYSIN in head and neck cancers

Oncolytics Biotech Inc. today announced that it has received approval from the Belgian Federal Agency for Medicines and Health Products (FAMHP) to conduct its Phase 3 trial examining REOLYSIN in combination with paclitaxel and carboplatin in patients with platinum-refractory head and neck cancers. This is the same trial that was agreed to by U.S. Food and Drug Administration (FDA) under the Special Protocol Assessment (SPA) process and the U.K. Medicines and Healthcare products Regulatory Agency (MHRA).

1 Jun 2010

First Edition: June 1, 2010

A number of today's headlines focus on the continuing role of health reform in national political calculations and strategies.

1 Jun 2010

Foods advertised on TV oversupply nutrients associated with chronic illness: Study

Making food choices based on television advertising results in a very imbalanced diet according to a new study comparing the nutritional content of food choices influenced by television to nutritional guidelines published in the June issue of the Journal of the American Dietetic Association.

1 Jun 2010

Commonalities between flies and humans make valuable new model for galactosemia

Galactosemia is a metabolic disease resulting from an inherited defect that prevents the proper metabolism of galactose, a sugar commonly found in dairy products, like milk. Exposure of affected people to galactose, can damage most of their organ systems and can be fatal. The ability to study the disease is limited by a lack of animal models.

1 Jun 2010

EpiCept provides update on post-approval commitments requested by EMA for Ceplene

EpiCept Corporation today provided an update on the post-approval commitments requested by the European Medicines Agency as part of its marketing authorization for Ceplene (histamine dihydrochloride). Ceplene is approved in the EU for remission maintenance and prevention of relapse in adults with Acute Myeloid Leukemia in first complete remission.

1 Jun 2010

Dendreon announces data presentation from 4 PROVENGE clinical trials at 105th AUA annual meeting

Dendreon Corporation today announced the presentation of safety data from the integrated analysis of four randomized PROVENGE® (sipuleucel-T) clinical trials of an autologous cellular immunotherapy in prostate cancer at the 105th Annual Scientific Meeting of the American Urological Association (AUA) in San Francisco.

1 Jun 2010

SQI Diagnostics second-quarter net loss increases to $2,021,000

SQI Diagnostics Inc., a medical systems automation company focused on evolving laboratory-based biomarker testing, today announced its financial and operational results for the second quarter ended March 31, 2010.

1 Jun 2010

PADF urges residents to put together emergency plans to survive during hurricane

On the eve of what is predicted to be one of the worst Atlantic hurricane seasons in years, the Pan American Development Foundation is urging residents in Central America and the Caribbean to put together emergency plans.

31 May 2010

Algal blooms in India threaten access to food, livelihood

The problem of toxic algae is not just confined to the Nordic countries - in India algal blooms are threatening poor people's access to food and their livelihoods, a problem that has been exacerbated by global warming. With funding from the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning and the Swedish International Development Cooperation Agency, researchers from the University of Gothenburg are to attempt to reduce the effects of algal blooms.

31 May 2010

Eating animals' meat hunted using lead ammunition can be dangerous for health: Study

Eating the meat of animals hunted using lead ammunition can be more dangerous for health than was previously thought, especially for children and people who consume large quantities. This is reflected in a study carried out by British and Spanish researchers that has been published by the journal PLos ONE.

31 May 2010

Researchers identify pattern of gene expression in kidney transplant recipients who don't need anti-rejection drugs

Researchers have identified a distinct pattern of gene expression in the largest reported group of kidney transplant recipients who have not rejected the transplant kidneys even though they stopped taking anti-rejection drugs. This finding may help identify other transplant recipients who could safely reduce or end use of immunosuppressive therapy. In 2008, more than 80,000 people in the United States were living with a kidney transplant.

31 May 2010

St. Jude Garden provides fresh produce to patients, staff

Harvesting fruits, vegetables and herbs at the peak of freshness is a recipe for good taste, but it also offers higher nutritional value which is important to the patients and staff at St. Jude Children's Research Hospital.

29 May 2010

FDA warns consumers not to purchase or use Arrow Brand Medicated Oil & Embrocation

The U.S. Food and Drug Administration today warned consumers not to purchase or use a product called "Arrow Brand Medicated Oil & Embrocation," also labeled as "Aceite Medicinal La Flecha (Spanish) or "箭嘜驅風油 (Mandarin)." The product is potentially toxic and contains two substances, methyl salicylate and camphor, which are poisonous when ingested.

29 May 2010

Developing countries must have food production capacity to avoid food price crisis, U.S. official says

Factors that resulted in higher food prices in several countries in 2008, such as food scarcity and the use of land for biofuels, are still present and could cause prices to rise again without food production improvements in developing countries, Ertharin Cousin, the U.S. ambassador to the U.N. food agencies in Rome, said in an interview with Reuters.

29 May 2010

Obama's National Security Strategy released, includes global health, food security priorities

"The Obama administration on Thursday released a sweeping statement of its national security goals," the Los Angeles Times reports. The 52-page document "calls for the United States to strengthen international institutions, to heed treaties and norms, and to build stronger ties to allies, including to the emerging powers of India, Brazil and China.

29 May 2010

FDA may seek criminal penalties against J & J for faulty recall of children's Tylenol, other medicines

The Wall Street Journal: "The Food and Drug Administration said it is weighing whether to seek criminal penalties against the Johnson & Johnson unit that made children's Tylenol and other over-the-counter kids' medicines recalled last month. Joshua Sharfstein, the FDA's principal deputy commissioner, told lawmakers at a hearing Thursday that J&J's McNeil Consumer Healthcare unit had a 'pattern of noncompliance' with good manufacturing practices.

29 May 2010

FDA approves Cysview for detection of non-muscle-invasive papillary cancer of bladder

GE Healthcare, a unit of General Electric Company, today announced that the US Food and Drug Administration has approved Cysview (hexaminolevulinate HCl) for the detection of non-muscle-invasive papillary cancer of the bladder in patients with known or suspected bladder cancer.

29 May 2010

Advaxis doses first patient in FDA-approved phase II CIN trial

Advaxis, Inc., the live, attenuated Listeria monocytogenes biotechnology company, has dosed the first patient in its US Food and Drug Administration -approved, phase II clinical trial in cervical intraepithelial neoplasia, commonly known as cervical dysplasia.

28 May 2010

Neptune's revenues increased by 8% for fiscal year ended February 28, 2010

Neptune Technologies & Bioressources Inc. today reports its consolidated financial results for the fiscal year ended February 28, 2010, announces the implementation of a shareholder rights plan and provides fiscal year highlights.

28 May 2010

Study shows infants fed Enfamil LIPIL experience improved immune outcomes

Results of a new study released this week in the June 2010 issue of The Journal of Pediatrics show that infants fed Enfamil LIPIL containing DHA and ARA during the first year of life experienced improved immune outcomes, including improved respiratory health, versus infants fed the same formulation without these beneficial lipids - and this health benefit was shown for the first three years of life.

28 May 2010

Food News and Research

Belgian FAMHP approves Oncolytics' Phase 3 combination trial of REOLYSIN in head and neck cancers

First Edition: June 1, 2010

Foods advertised on TV oversupply nutrients associated with chronic illness: Study

Commonalities between flies and humans make valuable new model for galactosemia

EpiCept provides update on post-approval commitments requested by EMA for Ceplene

Dendreon announces data presentation from 4 PROVENGE clinical trials at 105th AUA annual meeting

SQI Diagnostics second-quarter net loss increases to $2,021,000

PADF urges residents to put together emergency plans to survive during hurricane

Algal blooms in India threaten access to food, livelihood

Eating animals' meat hunted using lead ammunition can be dangerous for health: Study

Researchers identify pattern of gene expression in kidney transplant recipients who don't need anti-rejection drugs

St. Jude Garden provides fresh produce to patients, staff

FDA warns consumers not to purchase or use Arrow Brand Medicated Oil & Embrocation

Developing countries must have food production capacity to avoid food price crisis, U.S. official says

Obama's National Security Strategy released, includes global health, food security priorities

FDA may seek criminal penalties against J & J for faulty recall of children's Tylenol, other medicines

FDA approves Cysview for detection of non-muscle-invasive papillary cancer of bladder

Advaxis doses first patient in FDA-approved phase II CIN trial

Neptune's revenues increased by 8% for fiscal year ended February 28, 2010

Study shows infants fed Enfamil LIPIL experience improved immune outcomes

The future is bioengineered: Synthetic biology and global sustainability eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News